Vita Life Sciences (ASX:VLS) Interest Expense : A$-0.21 Mil (TTM As of Dec. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Vita Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Vita Life Sciences's interest expense for the six months ended in Dec. 2024 was A$ -0.11 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.21 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Vita Life Sciences's Operating Income for the six months ended in Dec. 2024 was A$ 6.34 Mil. Vita Life Sciences's Interest Expense for the six months ended in Dec. 2024 was A$ -0.11 Mil. Vita Life Sciences's Interest Coverage for the quarter that ended in Dec. 2024 was 58.67. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vita Life Sciences Interest Expense Historical Data

The historical data trend for Vita Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vita Life Sciences Interest Expense Chart

Vita Life Sciences Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Interest Expense

Get a 7-Day Free Trial

-0.17

-0.10

-0.03

-0.14

-0.21

Vita Life Sciences Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial															-	-0.01	-0.13	-0.10	-0.11

Vita Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.21 Mil.

Vita Life Sciences (ASX:VLS) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Vita Life Sciences's Interest Expense for the six months ended in Dec. 2024 was A$-0.11 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$6.34 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$0.21 Mil.

Vita Life Sciences's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Dec. 2024 )	/	Interest Expense (Q: Dec. 2024 )
	=	-1	*	6.336	/	-0.108
	=	58.67

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Vita Life Sciences Ltd has enough cash to cover all of its debt. Its financial situation is stable.

Vita Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vita Life Sciences Ltd (ASX:VLS) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bath Road Kirrawee, Unit 1/ 102, Sydney, NSW, AUS, 2232

Website

https://www.vitalifesciences.com

Vita Life Sciences Ltd is an Australian based pharmaceutical and healthcare company involved in formulating, packaging, sales, and distribution of vitamins and supplements. The company produces a wide range of premium supplements, vitamins, minerals, herbs and superfoods catered to all age categories and health conditions. The company markets its products through pharmacies and health food stores under the VitaHealth, Herbs of Gold brands throughout Asia-Pacific region. The company has four reportable segments which include The Australia segment comprises of sale of Herbs of Gold range in Australia and exports into China. The Singapore and Malaysia segment, comprise of Vitahealth and Herbs of Gold range in both countries The other market segment comprises of Vitahealth ranges.

Vita Life Sciences Headlines

No Headlines